CUSIP: 576810105
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,446,677
-
Share change
-
-6,114,703
-
Total reported value
-
$36,681,019
-
Price per share
-
$0.77
-
Number of holders
-
63
-
Value change
-
-$4,533,437
-
Number of buys
-
24
-
Number of sells
-
23
Quarterly Holders Quick Answers
What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 576810105:
Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q2 2020
As of 30 Jun 2020,
MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,446,677 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, Vivo Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, TWO SIGMA INVESTMENTS, LP, VICTORY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.